The use of diabetes specific nutritional formulas in the management of type 2 diabetes 24 September 2024 Advertisement For people living with type 2 diabetes, maintaining a healthy diet is one of the first steps for managing blood glucose levels (BGLs) and overall health.1 However, keeping up with all aspects of a diabetes management plan can be challenging. In fact, less than half of people with type 2 diabetes are able to maintain recommended dietary plans.2-6 This highlights the need for a simple and practical solution to support positive diabetes outcomes. Research shows that adding Diabetes Specific Nutritional Formulas (DSNFs) to a wholefoods diet can be beneficial for people living with type 2 diabetes. DSNFs have been clinically shown to support overall nutritional intake and assist in glycaemic management.7-12 Good nutrition is essential for diabetes management. Glucerna is a complete and balanced diabetes-specific nutritional formula (DSNF) scientifically formulated for individuals with diabetes, pre-diabetes or impaired glucose tolerance.13 Why Glucerna stands out Glucerna is backed by 30 years of scientific research14 and has been clinically shown to help: Manage blood glucose levels from day 1*12 Keep glucose levels within target range up to 90% of the time within 4 weeks^11 What’s in Glucerna? It’s scientifically designed with 4x Myo-Inositol **15-17 and a slow-release carbohydrate system.18,19 It’s a nutritionally complete and balanced low-GI diabetes supplement with 28 vitamins and minerals13and a heart healthy fat blend. 20 Glucerna is available in pharmacies. For more information visit the website. Diabetes Australia does not promote or encourage any single diet or eating plan and there is no one-size-fits-all approach to living well with diabetes. People with diabetes should make their own, informed choices about their diabetes management (including eating plans) in consultation with their diabetes healthcare team. Diabetes Australia does not promote any single product or brand. All Glucerna health claims can be found on the website. Food for Special Medical Purposes. Use under medical supervision. Glucerna is indicated for people with diabetes and/or impaired glucose tolerance as part of a diabetes management plan including diet and exercise. *In the 180 minutes following Glucerna consumption compared to oatmeal in people with type 2 diabetes. The study utlilised a previous Glucerna formulation. ^When used as a breakfast replacement as part of lifestyle modification, blood glucose was within the target glucose range of 3.9 – 10.0mmol/L for an average of 89.5% of the time in people with diabetes. The study utlilised a previous Glucerna formulation. **Compared to Glucerna® S434 per serving. References: 1. Australian Diabetes Society. Australian Blood Glucose Treatment Algorithm for Type 2 Diabetes [Available from: https://treatment.diabetessociety.com.au/plan/] accessed 8 August 2024. 2. Abate TW, et al. PLoS One. 2022;17(10):e0271378. 3. Han CY, et al. Proc Singapore Healthcare. 2020;29(2):81–90. 4. Paudel G, et al. J Glob Health. 2022;12:04056. 5. De Roxas R and Nicodemus Jr N. J ASEAN Fed Endocr Soc. 2013;28(2):134–142. 6. Broadbent E, et al. Diabetes Care. 2011;34(2):338–340. 7. Sanz-París A et al. Clinical Nutrition (Edinburgh, Scotland) 2020;39:3273–82. 8. Mottalib A et al. Nutrients 2016;8:443. doi: 10.3390/nu8070443. 9. Dávila AL et al. Nutrients 2019;11:1477. doi: 10.3390/nu11071477. 10. Chee WSS et al. BMJ Open Diabetes Res Care 2017;5:e000384. doi: 10.1136/bmjdrc-2016-000384. 11. Peng J et al. Br J Nutr 2019;121:560–66. 12. Devitt, A., et al. J Diabetes Res Clin Metab. 2012;1(1):20. 13. Glucerna Powder Product Label. 14. National Library of Medicine, PubMed 15. Bevilacqua A, et al. Int J Endocrinol. 2018:1968450. 16. Dang NT, et al. Biosci Biotechnol Biochem. 2010;74(5):1062–1067. 17. Yamashita Y, et al. J Agric Food Chem. 2013;61(20):4850–4854. 18. Glucerna Y495 GI test result. 19. Glucerna Y523 GI test result. 20. Heart Foundation (2019) Dietary fat & Heart Healthy Eating: Position Statement ANZ.2024.53395.GLU.1
Media releases 14 August 2026 Beyond blood glucose: New national partnership to measure how Australians with diabetes are really doing For the first time, the Australian Unity Wellbeing Index will be used to build the most complete picture yet of how diabetes affects Australian’s lives beyond clinical outcomes and health system costs, thanks to a partnership between Diabetes Australia, Deakin University, and the Australian Unity Support Foundation. Continue Reading
Media releases 13 August 2026 PMOS in spotlight for diabetes prevention A new partnership between Diabetes Australia and the Medibank Better Health Research Hub will support Monash University to develop a primary care model to better detect and prevent type 2 diabetes in women living with polyendocrine metabolic ovarian syndrome (PMOS). Continue Reading
News 7 August 2026 Brett Fenton appointed Adjunct Clinical Fellow at UTS Diabetes Australia warmly welcomes Chief Health Officer Brett Fenton's appointment as an Adjunct Clinical Fellow at the University of Technology Sydney (UTS). Continue Reading